Early detection could revolutionize tuberculosis prevention by identifying infections months before traditional symptoms emerge, potentially preventing transmission and enabling timely intervention in the world's leading infectious disease killer. A novel blood-based diagnostic technique successfully identified tuberculosis infections in household contacts of TB patients up to six months before they developed clinical disease. The dual-target digital droplet PCR assay detected circulating cell-free Mycobacterium tuberculosis DNA fragments in blood plasma with 79% sensitivity and 98% specificity when tested on high-risk individuals who later progressed to active tuberculosis. The method targets two specific bacterial insertion sequences, IS6110 and IS1081, achieving 91% sensitivity in asymptomatic cases and 82% in clinically uncertain cases. This represents a significant advance beyond current tuberculosis diagnostics, which typically require symptomatic disease or detectable bacterial loads in sputum samples. The technology addresses a critical gap in TB control programs, where approximately 25% of the global population harbors latent infections that can reactivate unpredictably. While promising, this single-center study of 138 household contacts requires validation in diverse populations and healthcare settings before clinical implementation. The approach could prove particularly valuable in high-burden regions where early detection might interrupt transmission chains, though cost-effectiveness and scalability remain unaddressed. The findings suggest blood-based molecular diagnostics may eventually complement existing screening methods, offering a non-invasive alternative to chest imaging and sputum testing for identifying pre-clinical tuberculosis in vulnerable populations.